Tag: St Jude Medical

Evidence in favour of DRG stimulation builds with real-world data

The real-world data collected in the PREDICT study has added to the evidence in favour of dorsal root ganglion (DRG) stimulation for the management...

Proclaim DRG Neurostimulation System introduced in Europe

Abbott has announced the European launch of the new Proclaim DRG Neurostimulation System, designed to deliver dorsal root ganglion (DRG) stimulation to patients suffering...

ACCURATE 12-month data published in Pain

New data published in the January edition of Pain has confirmed the superiority of dorsal root ganglion (DRG) stimulation therapy (from Abbott) over traditional...

Abbott completes the acquisition of St Jude Medical

Abbott has now completed the acquisition of St Jude Medical. The Abbott press release announcing the completion of the acquisition said, “The transaction provides...

CE mark for full body MR conditional labelling for Proclaim Elite...

The Proclaim Elite spinal cord stimulation (SCS) system (St Jude Medical) has received CE mark approval for full-body magnetic resonance (MR) conditional labelling. With...

Proclaim Elite spinal cord stimulation system earns full-body MRI compatibility labelling

The US Food and Drug Administration (FDA) has approved full-body magnetic resonance (MR) conditional labelling for the Proclaim Elite spinal cord stimulation (SCS) system (St Jude Medical)....

Southeast Pain Care uses new Axium neurostimulator for chronic pain

Southeast Pain Care is one of the first facilities in North Carolina, USA, to use a new neurostimulation device designed to relieve the sensation...
Researchers at Ohio State University, USA, say deep brain stimulation from a device similar to a cardiac pacemaker can slow the decline of problem-solving and decision-making skills in Alzheimer’s patients.

St Jude Medical shareholders approve merger with Abbott

St Jude Medical has announced that, based on the preliminary voting results from St Jude Medical’s Annual Meeting of Shareholders held on 26 October, St...

Infinity deep brain stimulation system approved in the USA

St Jude Medical has announced the United States Food and Drug Administration approval and first implant of the Infinity deep brain stimulation (DBS) system...

FDA approves BurstDR stimulation for patients with chronic pain

The US Food and Drug Administration (FDA) has approved BurstDR stimulation, a physician-designed form of spinal cord stimulation (SCS) clinically proven to provide superior outcomes for...

Most patients with chronic trunk or limb pain experience “substantial” pain...

Twenty-four month data from a postmarket, clinical registry have found that most patients suffering from chronic pain of the trunk and/or limbs reported “substantial”...

St Jude Medical launches Infinity deep brain stimulation system and directional...

St Jude Medical has launched the Infinity deep brain stimulation (DBS) system and directional DBS lead in Europe. The system, which received CE mark approval...

First US commercial implants of Axium DRG system announced

St Jude Medical has announced the US launch and first post-approval implants of the St Jude Medical Axium Neurostimulator System for dorsal root ganglion (DRG) stimulation...

St. Jude Medical: Returning innovation to chronic pain treatment

With a series of acquisitions and recent product approvals, St. Jude Medical has further solidified its place as a leading provider of treatment options...

SUNBURST data demonstrates superior pain relief results for Burst Stimulation over...

St Jude Medical’s Burst stimulation can relieve chronic pain more effectively than traditional tonic spinal cord stimulation (SCS), according to the SUNBURST study. The...

St Jude Medical launches spinal cord stimulation system in Europe

St Jude Medical has launched its Proclaim Elite spinal cord stimulation (SCS) system in Europe. According to a press release, this is the world’s...

FDA approves Proclaim Elite SCS System

St Jude Medical has announced FDA approval of the new Proclaim Elite Spinal Cord Stimulation System, the first and only upgradeable and recharge-free spinal cord stimulation (SCS)...

FDA clears St Jude Medical Invisible Trial System

St Jude Medical has received Food and Drug Administration (FDA) approval of the Invisible Trial System. The system, which received CE mark in June...

St Jude Medical completes acquisition of Spinal Modulation

Now complete, the acquisition of Spinal Modulation adds DRG stimulation technology to the St Jude Medical chronic pain portfolio.

St Jude Medical announces intent to acquire Spinal Modulation

Following the completion of this acquisition, St Jude Medical will become the only medical device manufacturer to offer radiofrequency ablation (RFA), spinal cord stimulation (SCS) and dorsal root ganglion (DRG) stimulation therapy solutions for the treatment of chronic pain.